Results
|
341.
|
|
|
342.
|
|
|
343.
|
|
|
344.
|
|
|
345.
|
Phase II study of gemcitabine and bexarotene (GEMBEX) in the treatment of cutaneous T-cell lymphoma. [electronic resource] by
- Illidge, T
- Chan, C
- Counsell, N
- Morris, S
- Scarisbrick, J
- Gilson, D
- Popova, B
- Patrick, P
- Smith, P
- Whittaker, S
- Cowan, R
Producer: 20140106
In:
British journal of cancer vol. 109
Availability: No items available.
|
|
346.
|
|
|
347.
|
|
|
348.
|
|
|
349.
|
|
|
350.
|
|
|
351.
|
|
|
352.
|
|
|
353.
|
Design and synthesis of potent retinoid X receptor selective ligands that induce apoptosis in leukemia cells. [electronic resource] by
- Boehm, M F
- Zhang, L
- Zhi, L
- McClurg, M R
- Berger, E
- Wagoner, M
- Mais, D E
- Suto, C M
- Davies, J A
- Heyman, R A
Producer: 19950914
In:
Journal of medicinal chemistry vol. 38
Availability: No items available.
|
|
354.
|
|
|
355.
|
|
|
356.
|
|
|
357.
|
|
|
358.
|
Targeting TR4 nuclear receptor with antagonist bexarotene increases docetaxel sensitivity to better suppress the metastatic castration-resistant prostate cancer progression. [electronic resource] by
- Hu, Linyi
- Sun, Yin
- Luo, Jie
- He, Xiang
- Ye, Meihua
- Li, Gonghui
- Zhang, Yong
- Bai, Jian
- Zhang, Dahong
- Chang, Chawnshang
Producer: 20201124
In:
Oncogene vol. 39
Availability: No items available.
|
|
359.
|
Bexarotene Attenuates Focal Cerebral Ischemia-Reperfusion Injury via the Suppression of JNK/Caspase-3 Signaling Pathway. [electronic resource] by
- Liu, Hailin
- Liu, Shengwei
- Tian, Xiaocui
- Wang, Qian
- Rao, Jiangyan
- Wang, Yucun
- Xiang, Fei
- Zheng, Hang
- Xu, Lu
- Dong, Zhi
Producer: 20200330
In:
Neurochemical research vol. 44
Availability: No items available.
|
|
360.
|
|